drugset / Trial / NCT02234427

Pharmacogenomics of Antiplatelet Response

NCT02234427 ↗

Phase 4 Completed 34 enrolled Johns Hopkins University
NaSingle-groupOpen-labelBasic science

Summary

This clinical trial will examine with effect of 2-week aspirin therapy on platelet gene expression in persons at high-risk of developing heart attacks due to family history of early-onset coronary artery disease

Timeline

Start
2014-06
Primary completion
2015-04
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 81 mg —

Indications